EPO Patent Grant EP3575389B1 - Consumer Products With Protease Variants
Summary
The European Patent Office has granted patent EP3575389B1 for consumer products containing protease variants. This patent, effective March 18, 2026, covers innovations related to detergent compositions and their use in cleaning applications.
What changed
The European Patent Office (EPO) has granted patent EP3575389B1, titled "Consumer Products With Protease Variants." This patent, which becomes effective on March 18, 2026, relates to novel protease variants and their application in consumer products, particularly cleaning agents. The grant signifies the EPO's recognition of the inventive step and industrial applicability of the claimed technology.
For manufacturers in the consumer products sector, especially those involved in detergent formulation, this patent grant may impact product development and market entry. Companies should review the patent's claims to ensure their products do not infringe on the granted intellectual property rights. While this is a patent grant and not a regulatory rule imposing direct compliance obligations, it establishes exclusive rights for the patent holder in designated European states.
Source document (simplified)
CONSUMER PRODUCTS WITH PROTEASE VARIANTS
Grant EP3575389B1 Kind: B1 Mar 18, 2026
Inventors
SOUTER, Philip Frank, WARD, Glenn Steven, POULOSE, Ayrookaran Joseph, ESTELL, David A, KELLIS, Jr. James T., COLLIER, Katherine D., CASCAO-PEREIRA, Luis Gustavo, ALEKSEYEV, Viktor Yuryevich, AMIN, Neelam S., YAO, Jian, AUGUSTYN, Katherine
IPC Classifications
C11D 3/386 20060101AFI20200127BHEP C12N 9/54 20060101ALI20200127BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.